Food and Drug Administration The agency has issued warning letters to stop the distribution of illegally marketed semaglutide, saying the drugs may be counterfeit, which means they could contain the wrong ingredients, contain too little, too much or no active ingredient at all, or contain other harmful ingredients. In July, it said that it had received reports of dosing errors with compounded semaglutide injectable products, some of which landed patients in the hospital
Melbourne Bariatric and Endoscopic Surgeon Dr Jason Winnett says, The treatment of obesity is not like taking paracetamol to treat a cold, or an infection where you take antibiotics and youre done
Potential improvements include: Better blood sugar regulation Improved insulin sensitivity Reduced visceral fat Lower cardiometabolic risk factors Improved metabolic function Excess body weight is closely associated with insulin resistance and metabolic dysfunction
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
Semaglutide activates GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors